ARTICLE | Company News
M&E, AstraZeneca deal
January 2, 2001 8:00 AM UTC
MEBIO granted AZN non-exclusive access to its CellScreen technology that allows identification of validated targets by genetic manipulation of intracellular processes. MEBIO will receive a technology ...